Likewise, in the same cancer, an LSD1 inhibitor, ORY1001, favored Notch1 expression and suppressed tumor growth in vitro and in vivo through Notch-dependent ASCL1 repression [157]. The gene discussed is NOTCH1; the disease is neoplasm.